Novartis AG: meeting of 15 Sep 2023

Votes reported on Form N-PX, item by item

252 Form N-PX filers reported votes at the Novartis AG meeting of 15 Sep 2023. Their records fall into 5 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

1 vote records from 1 filers. 0 of the 1 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management1 filers100.0% for0.0% against0.0% against management25,285 reported shares

EXTRAORDINARY TRANSACTIONSIssuer

EXTRAORDINARY TRANSACTIONS: management items

Management items in this category are shown together; filers word and number them differently.

529 vote records from 248 filers. 3 of the 234 filers that marked the item either way voted against management. 14 filers reported this item without a management mark.

92.7% for0.4% against6.9% other1.3% against management248 filers100.0% for0.0% against0.0% other0.0% against management19,765,553,076 reported shares, counted once per item in this group

CAPITAL STRUCTUREIssuer

CAPITAL STRUCTURE: management items

Management items in this category are shown together; filers word and number them differently.

543 vote records from 251 filers. 2 of the 235 filers that marked the item either way voted against management. 16 filers reported this item without a management mark.

92.4% for0.0% against7.6% other0.9% against management251 filers100.0% for0.0% against0.0% other0.0% against management19,768,487,472 reported shares, counted once per item in this group

CORPORATE GOVERNANCEIssuer

CORPORATE GOVERNANCE: management items

Management items in this category are shown together; filers word and number them differently.

463 vote records from 216 filers. 198 of the 206 filers that marked the item either way voted against management. 10 filers reported this item without a management mark.

1.9% for87.5% against10.6% other96.1% against management216 filers0.0% for99.8% against0.2% other100.0% against management19,756,196,839 reported shares, counted once per item in this group

OTHERIssuer

OTHER: management items

Management items in this category are shown together; filers word and number them differently.

275 vote records from 42 filers. 29 of the 36 filers that marked the item either way voted against management. 6 filers reported this item without a management mark.

16.7% for64.3% against19.0% other80.6% against management42 filers9.6% for86.3% against4.1% other92.7% against management11,095,032 reported shares, counted once per item in this group

How the largest families voted

None of the families tracked on this site reported a position on these items.

Questions

How did large funds vote at the Novartis AG meeting?

252 Form N-PX filers reported votes at the meeting of 15 Sep 2023. On say-on-pay, 0 of 1 voted against management (0.0%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Novartis AG on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Novartis AG

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Novartis AG with a meeting date within three days of 15 Sep 2023. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.